Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | F2R | P25116 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.31 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.30 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.30 |
| ▸ | NPY2R | P49146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21707903 | 0.94 | HDAC8 (0.39) | HDAC8GPBAR1TRPV4HDAC1HDAC6 | |
| SCHEMBL21707901 | 0.92 | HDAC8 (0.39) | HDAC8GPBAR1TRPV4HDAC1HDAC6 | |
| SCHEMBL21707904 | 0.90 | HDAC8 (0.41) | HDAC8GPBAR1TRPV4HDAC1HDAC6 | |
| SCHEMBL21693652 | 0.90 | HDAC8 (0.36) | HDAC8GPBAR1TRPV4HDAC1HDAC6 | |
| SCHEMBL21705045 | 0.88 | HDAC8 (0.35) | HDAC8GPBAR1HDAC1HDAC6F2R | |
| SCHEMBL29379388 | 0.88 | HDAC8 (0.35) | HDAC8GPBAR1HDAC1HDAC6F2R | |
| SCHEMBL28362281 | 0.87 | SLC6A2 (0.36) | HDAC8GPBAR1HDAC1HDAC6MEN1 | |
| SCHEMBL23264279 | 0.86 | PDE4B (0.34) | HDAC8GPBAR1HDAC1HDAC6 | |
| SCHEMBL29431906 | 0.86 | PDE4B (0.34) | HDAC8GPBAR1HDAC1HDAC6 | |
| SCHEMBL21693739 | 0.86 | RXFP1 (0.36) | HDAC8HDAC1HDAC6HSD11B1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020030095-A1 | PHARMACEUTICAL COMPOSITION CONTAINING META-DIAMIDE COMPOUND AND USE THEREOF | 上海泰禾国际贸易有限公司 | 2020-02-13 | — | — | WO | disclosed |